<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37400798</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>Hemophagocytic lymphohistiocytosis secondary to virus infection and followed by lupus nephritis recurrence in a renal transplantation pediatric recipient: a case report.</ArticleTitle><Pagination><StartPage>200</StartPage><MedlinePgn>200</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">200</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-023-03249-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening disorder characterized by systemic inflammation and organ failure as a result of dysregulated immune cell activation. HLH can be induced by a variety of factors including infection, tumours and autoimmune disease and can also occur in patients following solid organ transplantation. Occurrence of HLH and lupus nephritis (LN) successively within a short period of time after renal transplantation is uncommon.</AbstractText><AbstractText Label="CASE PRESENTATION">We described an 11-year-old female post-transplant patient who presented with hemocytopenia, fever, elevated serum ferritin, splenomegaly, hyperlipidemia, and hypofibrinemia, and was clinically diagnosed with HLH. After comprehensive treatment with corticosteroids, intravenous immunoglobulin (IVIG), and reducing immunosuppressants, her condition improved, but then hematuria ensued. The transplant kidney biopsy showed LN. She was treated with hydroxychloroquine and methylprednisolone while intensive immunosuppressive agents were given. She has remained in remission for two years until now.</AbstractText><AbstractText Label="CONCLUSIONS">The main inducing factors of HLH should be identified as early as possible, and accurate treatment plans should be taken. The long-course IVIG regimen may be one of the effective treatments for virus-induced HLH. After remission of HLH, we need to be alert to the recurrence of autoimmune diseases in patients with underlying diseases, and timely increase immunosuppressants.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jiyuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xuejing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Danyi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Wendan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Hengchang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Mingyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Helong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Organ Transplantation in Hunan Province, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Immunology Center, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Xubiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Longkai</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Fenghua</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China. pfh3327@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051359" MajorTopicYN="Y">Lymphohistiocytosis, Hemophagocytic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hemophagocytic lymphohistiocytosis (HLH)</Keyword><Keyword MajorTopicYN="N">Lupus nephritis (LN)</Keyword><Keyword MajorTopicYN="N">Renal transplant</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus (SLE)</Keyword><Keyword MajorTopicYN="N">Virus infection</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>4</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37400798</ArticleId><ArticleId IdType="pmc">PMC10316544</ArticleId><ArticleId IdType="doi">10.1186/s12882-023-03249-4</ArticleId><ArticleId IdType="pii">10.1186/s12882-023-03249-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hayden A, Park S, Giustini D, Lee AYY, Chen LYC. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev. 2016;30(6):411&#x2013;20. doi: 10.1016/j.blre.2016.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2016.05.001</ArticleId><ArticleId IdType="pubmed">27238576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponticelli C, Alberighi ODC. Haemophagocytic syndrome&#x2013;a life-threatening complication of renal transplantation. Nephrol Dial Transplant. 2009;24(9):2623&#x2013;7. doi: 10.1093/ndt/gfp282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfp282</ArticleId><ArticleId IdType="pubmed">19525363</ArticleId></ArticleIdList></Reference><Reference><Citation>Campo M, Berliner N. Hemophagocytic lymphohistiocytosis in adults. Hematol Oncol Clin North Am. 2015;29(5):915&#x2013;25. doi: 10.1016/j.hoc.2015.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hoc.2015.06.009</ArticleId><ArticleId IdType="pubmed">26461151</ArticleId></ArticleIdList></Reference><Reference><Citation>Smits BM, van Montfrans J, Merrill SA, van de Corput L, van Gijn M, de Vries A, van den Bos C, Abbink F, van der Molen RG, Dors N, et al. A minimal parameter set facilitating early decision-making in the diagnosis of Hemophagocytic Lymphohistiocytosis. J Clin Immunol. 2021;41(6):1219&#x2013;28. doi: 10.1007/s10875-021-01005-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01005-7</ArticleId><ArticleId IdType="pmc">PMC8310853</ArticleId><ArticleId IdType="pubmed">33779897</ArticleId></ArticleIdList></Reference><Reference><Citation>Vald&#xe9;s Franc&#xed; E, Perez Flores I, Candel FJ, de la Moreno MA, Romero NC, Rodr&#xed;guez Cubillo B, Lucena Valverde R, S&#xe1;nchez Fructuoso AI. Hemophagocytic syndrome triggered by donor-transmitted toxoplasmosis as a complication in same-donor recipients of renal transplantation: case report and review of the literature. Transpl Infect Dis. 2021;23(6):e13732. doi: 10.1111/tid.13732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13732</ArticleId><ArticleId IdType="pubmed">34533259</ArticleId></ArticleIdList></Reference><Reference><Citation>Henter J-I, Horne A, Aric&#xf3; M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124&#x2013;31. doi: 10.1002/pbc.21039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.21039</ArticleId><ArticleId IdType="pubmed">16937360</ArticleId></ArticleIdList></Reference><Reference><Citation>Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613&#x2013;20. doi: 10.1002/art.38690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38690</ArticleId><ArticleId IdType="pubmed">24782338</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffen CJ, Koch N, Eckardt KU, Amann K, Seelow E, Schreiber A. Hemophagocytic lymphohistiocytosis and thrombotic microangiopathy after parvovirus B19 infection and renal transplantation: a case report. BMC Nephrol. 2021;22(1):337. doi: 10.1186/s12882-021-02538-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-021-02538-0</ArticleId><ArticleId IdType="pmc">PMC8506469</ArticleId><ArticleId IdType="pubmed">34641801</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh NS, Pagano AL, Hays AJ, Kats A, Dahl SM, Warady BA, Beins NT, Yin DE. Ehrlichia-induced hemophagocytic lymphohistiocytosis in a pediatric kidney transplant recipient. Pediatr Transpl. 2022;26(1):e14134. doi: 10.1111/petr.14134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/petr.14134</ArticleId><ArticleId IdType="pubmed">34595809</ArticleId></ArticleIdList></Reference><Reference><Citation>Naciso J&#xfa;nior J, Neri BdO, Dantas GLdA. Silveira LdHJ, sales MLdMBO, Freitas TVdS, Esmeraldo RdM: secondary hemophagocytic syndrome after renal transplantation: two case-reports. Jornal Brasileiro de Nefrologia. 2020;42(1):118&#x2013;23. doi: 10.1590/2175-8239-jbn-2018-0246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/2175-8239-jbn-2018-0246</ArticleId><ArticleId IdType="pmc">PMC7213938</ArticleId><ArticleId IdType="pubmed">31419275</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentata Y. Parvovirus B19 in kidney transplantation: key points and essential pitfalls to know. Infect Dis (Lond) 2021;53(6):404&#x2013;8. doi: 10.1080/23744235.2021.1893379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1893379</ArticleId><ArticleId IdType="pubmed">33641590</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Zeng C, Cheng J, Zhou J, Gu J, Mao X, Zhang W, Cao Y, Luo H, Xu B, et al. Determination of Epstein-Barr Virus-Infected lymphocyte cell types in Peripheral Blood mononuclear cells as a Valuable Diagnostic Tool in Hematological Diseases. Open Forum Infect Dis. 2019;6(5):ofz171. doi: 10.1093/ofid/ofz171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz171</ArticleId><ArticleId IdType="pmc">PMC6499900</ArticleId><ArticleId IdType="pubmed">31065564</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng G-Q, Wang J-S, Wang Y-N, Wei N, Wang Z. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection. Int Immunopharmacol. 2021;96:107606. doi: 10.1016/j.intimp.2021.107606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107606</ArticleId><ArticleId IdType="pubmed">33826999</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras G, Mattiazzi A, Guerra G, Ortega LM, Tozman EC, Li H, Tamariz L, Carvalho C, Kupin W, Ladino M, et al. Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrology: JASN. 2010;21(7):1200&#x2013;7. doi: 10.1681/ASN.2009101093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2009101093</ArticleId><ArticleId IdType="pmc">PMC3152228</ArticleId><ArticleId IdType="pubmed">20488956</ArticleId></ArticleIdList></Reference><Reference><Citation>Goral S, Ynares C, Shappell SB, Snyder S, Feurer ID, Kazancioglu R, Fogo AB, Helderman JH. Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation. 2003;75(5):651&#x2013;6. doi: 10.1097/01.TP.0000053750.59630.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TP.0000053750.59630.83</ArticleId><ArticleId IdType="pubmed">12640304</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg G, Blohm&#xe9; I, Persson H, Olausson M, Svalander C. Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study. Nephrol Dial Transplant. 1992;7(11):1116&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">1336139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-M, Kwok S-K, Ju JH, Kim H-Y, Park S-H. Reactive hemophagocytic syndrome in adult korean patients with systemic lupus erythematosus: a case-control study and literature review. J Rheumatol. 2012;39(1):86&#x2013;93. doi: 10.3899/jrheum.110639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.110639</ArticleId><ArticleId IdType="pubmed">22174206</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae MN, Kwak DH, Park SJ, Choi BS, Park CW, Choi YJ, Lee JW, Yang CW, Kim Y-S, Chung BH. Acute kidney injury induced by thrombotic microangiopathy in a patient with hemophagocytic lymphohistiocytosis. BMC Nephrol. 2016;17:4. doi: 10.1186/s12882-015-0217-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-015-0217-z</ArticleId><ArticleId IdType="pmc">PMC4704296</ArticleId><ArticleId IdType="pubmed">26739581</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>